The data showed that COM33 or carboplatin alone delayed tumor growth but did not reach statistical significance ( Figure 5 A,B).
← all excerpts
COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer.
1
—
—